Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
top of page
BPIQ Blog
Jun 21, 20223 min read
Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 20223 min read
Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 17, 20225 min read
EASL's International Liver Congress (ILC) 2022 - Clinical Presentations
Updated 6/27/22 Summary The International Liver Congress (ILC) 2022 is taking place from June 22 - 26 in-person at ExCeL in London and...
Jun 15, 20221 min read
Biopharma Daily Stock Updates - 06/15/22
$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...
Jun 15, 20221 min read
Free Biopharma Daily Stock Updates - 06/15/22
$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page